Company Overview and News
Stop missing out on important events!
Canopy Growth Corp., one of the world's biggest medical marijuana producers, now wants to take on the world's pharmaceutical giants. (28-0)
OrganiGram (OTCQB:OGRMF) sits in one of the more unique positions in the Canadian cannabis sector. It is one of the largest mid-size companies in the market, and is likely to maintain that position over the next year or two, unless it decides to change its domestic business model. (18-0)
Feb 16 (Reuters) - Canada’s main stock index was little changed on Friday as a boost from the heavyweight energy sector was offset by a decline in gold and natural resource companies, as well as cannabis producers. (47-0)
TORONTO, Feb 16 (Reuters) - Canopy Growth Corp, one of the world’s biggest medical marijuana producers, now wants to take on the world’s pharmaceutical giants. (28-0)
TORONTO (Reuters) - Canopy Growth Corp, one of the world’s biggest medical marijuana producers, now wants to take on the world’s pharmaceutical giants. (28-0)
Sales volume, mix, and selling prices are key drivers for Canopy Growth’s (WEED) sales as well as for companies (HMLSF) such as Aphria (APHQF), Aurora Cannabis (ACBFF), and MedReleaf (MEDFF). Let’s look at how Canopy Growth performed on these fronts. (18-0)
In the earlier part of this series, we discussed Canopy Growth’s sales drivers and how the company’s selling prices increased year-over-year. At the same time, the company also managed to lower its cost of production. In its press release, Canopy Growth reported that its per gram weighted average cost before shipping and fulfillment fell 39% to 1.03 Canadian dollars from 1.7 Canadian dollars in 3Q17. (18-0)
In the earlier parts of this series, we discussed how Canopy Growth (WEED) fared in terms of selling prices, sales volumes, and cost of production. While the company’s cost of production fell 1.9% year-over-year, its selling price rose 13% over the same period. (18-0)
In preparation for the expected legalization of recreational cannabis in Canada, Canopy Growth’s (WEED) chair and CEO Bruce Linton stated, “Success in future global medical markets and the recreational cannabis market in Canada will depend not only on capacity but on strong execution and securing supply agreements with the provinces today.” (18-0)
There has been a great deal of enthusiasm recently among investors (MJX) when it comes to cannabis stocks. Of course, the biggest catalyst for sales growth has come from recreational use in Canada. In addition, an increase in medical and recreational cannabis use around the world may also drive sales growth for these companies. (18-0)
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com (14-1)
* AURORA CANNABIS - SIGNED LOI WITH SOCIÉTÉ DES ALCOOLS DU QUÉBEC TO SUPPLY A MINIMUM OF 5,000 KG OF CANNABIS/ANNUM FOR QUEBEC ADULT CONSUMER MARKET Source text for Eikon: Further company coverage: (8-0)
Aurora Cannabis (OTCQX:ACBFF) reported its second quarter fiscal 2018 results last week. The cannabis industry has been in the spotlight lately as investors focus on the upcoming legalization. The current medical market is expected to expand but the recreational market represents the bulk of the eventual consumption. Aurora is currently building out its Aurora Sky facility and its pending acquisition of CanniMed (OTC:CMMDF) will further boost its production profile and customer base. (18-0)
Future value will depend on THCX's ability to sell tens of thousands of kilograms of cannabis, while they currently sell 120 kg/quarter. (19-1)
The cannabis stocks are transitioning from the first stage of the bull market to the second stage. This means investors should change their portfolio strategy. (21-4)
ACBFF : Aurora Cannabis (TSXV:ACB) Analysis and Research Report
Aurora Cannabis is a community minded, Canadian owned and operated company. Nestled in the shadow of the Rockies in Mountain View County, its plants are carefully brought to harvest in its purpose-built 55,200 square foot facility.
Fed with water from the Canadian Rockies, cared for in a state-of-the-art facility designed to produce the cleanest, safest medical cannabis available on the market, we're proud of its facility, its team and its product. Cultivating, harvesting, and selling Canadian Medical Marijuana, Aurora is your best chance to experience the healing power of nature.
On November 27th, 2015 Aurora was officially issued its license to sell. This marked a monumental step in the continued success and evolution of Aurora as one of Canada's top medical marijuana companies.
Aurora is one of 35 licensed producers across Canada and the only one located in Alberta. Boasting the second highest square footage approved for production in Canada, Aurora was the first applicant ...